Babar, M. et al. 2021. COMPARISON OF EFFICACY AND SAFETY PROFILE OF EMPAGLIFLOZIN AS A COMBINATION THERAPY IN OBESE TYPE 2 DIABETIC PATIENTS. Journal of Ayub Medical College Abbottabad. 33, 2 (Apr. 2021), 188–191.